Прилуцька С. В.Didenko, G. V.G. V.DidenkoPotebnya, G. P.G. P.Potebnya0000-0003-0202-8042Богуцька, Катерина ІванівнаКатерина ІванівнаБогуцька0000-0002-9847-4137Прилуцький, Юрій ІвановичЮрій ІвановичПрилуцькийRitter, U.U.RitterScharff P.2025-08-262025-08-262014Prylutska, S. V., Didenko, G. V., Potebnya, G. P., Bogutska, K. I., Prylutskyy, Y. I., Ritter, U., & Scharff, P. (2014). Toxic effect of C60 fullerene-doxorubicin complex towards tumor and normal cells in vitro. Biopolymers and Cell, 30(5), 372–376. doi:10.7124/bc.0008b4UDC 57.085.23 + 576.3: 616-006.0410.7124/bc.0008B4https://ir.library.knu.ua/handle/15071834/7267Creation of new nanostructures possessing high antitumor activity is an important problem of modern biotechnology. Aim. To evaluate cytotoxicity of created complex of pristine C60 fullerene with the anthracycline antibiotic doxorubicin (Dox), as well as of free C60 fullerene and Dox, towards different cell types – tumor, normal immunocompetent and hepatocytes. Methods. Measurement of size distribution for particles in C60 + Dox mixture was performed by a dynamic light scattering (DLS) technique. Toxic effect of C60 + Dox complex in vitro towards tumor and normal cells was studied using the MTT assay. Results. DLS experiment demonstrated that the main fraction of the particles in C60 + Dox mixture had a diameter in the range of about 132 nm. The toxic effect of C60 + Dox complex towards normal (lymphocytes, macrophages, hepatocytes) and tumor (Ehrlich ascites carcinoma, leukemia L1210, Lewis lung carcinoma) cells was decreased by ~10–16 % and ~7–9 %, accordingly, compared with the same effect of free Dox. Conclusions. The created C60 + Dox composite may be considered as a new pharmacological agent that kills effectively tumor cells in vitro and simultaneously prevents a toxic effect of the free form of Dox on normal cells.enС60 fullerene-doxorubicin complexnormal and tumor cellscytotoxicityMTT assaydynamic light scatteringСтаття